Plus

Inside Trump’s $50B Pharma Deal with AstraZeneca

New deal to slash drug prices under his “Most Favored Nation” plan.

Both promise lower prices for Medicaid and new meds.

Buy meds direct from drugmakers — up to 80% off for chronic illnesses.

AstraZeneca investing $50B in U.S. manufacturing, incl. a $4.5B Virginia plant.

Drug giants get a 3-year tariff break for joining the plan.

 Experts call the numbers “unclear” — some even “impossible.”

U.S. may pay less, but other countries could pay more.

Big promise — real savings still TBD.

Dashed Trail

Liked this story?

Click  to explo

Next

Top 10 Most Fuel-Efficient Hybrids in America

Share